The stock market

Stocks Extend Gain as ‘Not That Many Bears Left’: Markets Wrap​

By
Vildana Hajric
and
Kamaron Leach
August 24, 2021, 6:06 PM EDT Updated on August 25, 2021, 4:02 PM EDT

“There are not that many bears left,” Irene Tunkel, chief U.S. equity strategist at BCA Research, said by phone. Pullbacks like last week’s are becoming “shallower and shallower” as more people buy the dip, she said. “There is very, very strong buy-the-dip mentality.”

NOT A GOOD SIGN WHEN THE HERD IS ALL ON ONE SIDE OF THE BOAT
 

The Executive Group President of The Estée Lauder Companies Inc. (NYSE:EL), John Demsey, Just Sold 76% Of Their Holding​

BySimply Wall StPublishedAugust 26, 2021
NYSE:EL
Source: Shutterstock
Some The Estée Lauder Companies Inc. (NYSE:EL) shareholders may be a little concerned to see that the Executive Group President, John Demsey, recently sold a substantial US$2.1m worth of stock at a price of US$328 per share. Probably the most concerning element of the whole transaction is that the disposal amounted to 76% of their entire holding.
See our latest analysis for Estée Lauder Companies

Estée Lauder Companies Insider Transactions Over The Last Year​

In the last twelve months, the biggest single sale by an insider was when the insider, Aerin Lauder, sold US$66m worth of shares at a price of US$300 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$335. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. This single sale was just 44% of Aerin Lauder's stake.
Estée Lauder Companies insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
 
some do live all the time...meetings...teachers etc


i can see the clothes industry business taking a beating but beauty aids are still going strong
 
some do live all the time...meetings...teachers etc


i can see the clothes industry business taking a beating but beauty aids are still going strong
That is how Lauder & most companies are operating - on line meetings - multiple times during the day from what I'm being told by my former colleagues.

Also - many businesses are beginning to reopen with people heading into their offices. My whole former department has been relocated into Manhattan from the Island. Glad I retired when I did. Having to schlep into NYC twice a week to attend meetings was enough for me.

And it's not just make up. Their skincare side of the business is actually larger then the make up side.
 
Interesting to see how the cards tumble when someone shakes the table that they were stacked up on. This trial may also be fodder for the tabloids with the "secret romantic relationship, etc." Theranos caused a bit of a stir during my career with Corporate VPs riding me to figure out how they could do all those tests, for so little money and sample volume. When they were shown to be charlatans, things calmed down a bit...

Fallen tech star Elizabeth Holmes prepares to go on trial​

pressherald.com/2021/09/01/fallen-tech-star-elizabeth-holmes-prepares-to-go-on-trial/

By MICHAEL LIEDTKE September 1, 2021
Theranos Founder Fraud Trial
Elizabeth Holmes, founder and CEO of Theranos, arrives at the federal courthouse for jury selection in her trial Tuesday in San Jose, Calif. Holmes faces 12 felony counts alleging she engineered a massive fraud that duped rich investors with a blood-testing technology that she promised would be able to screen for hundreds of diseases with a finger prick. Associated Press/Nic Coury

Jury selection in the fraud trial of Theranos founder Elizabeth Holmes began Tuesday, casting a spotlight on the fallen Silicon Valley star now facing felony charges alleging she duped elite financial backers, customers and patients into believing that her startup was about to revolutionize medicine.

But the Theranos technology, which promised to run hundreds of medical tests using a single drop of blood, never lived up to expectations, and may never have worked at all.

Once a jury is seated, the trial will begin in San Jose, California, with opening arguments scheduled early next week. The trial will revolve around the rise and fall of Theranos, a startup that Holmes launched after dropping out of Stanford University in 2003.

At one point, it looked like Holmes might realize her lofty ambitions of becoming the next Steve Jobs, the Apple co-founder she embraced as a role model. Not that long ago, business magazines hailed the similarities, featuring Holmes in cover stories about her vision and her estimated fortune $4.5 billion based on her stake in Theranos.

But Theranos — a name derived from the words “therapy” and “diagnosis” — quickly lost steam after revelations that its supposedly breakthrough blood-testing machine, called “Edison,” didn’t work as Holmes had described and produced dangerously inaccurate results in tests run for actual patients.

Holmes now faces the prospect of being remembered more like Bernie Madoff, the once-revered New York financier whose name became synonymous with fraud after he pled guilty to bilking billions of dollars through an illegal Ponzi scheme. If convicted, Holmes, now 37, could be sentenced to as much as 20 years in prison.

Holmes, who was in court Tuesday, has maintained her innocence since the U.S. government charged her in 2018. Her trial was delayed by the pandemic and then a pregnancy that culminated in the recent birth of a son. Some legal observers believe that could make her a more sympathetic figure before the jury.
Jury selection is expected to take several days. Holmes’ saga has received wide attention thanks to a book by a Wall Street Journal investigative reporter whose newspaper stories led to her company’s downfall and an HBO documentary called “The Inventor.” She is also about to become the subject of a TV miniseries called “The Dropout,” starring Amanda Seyfried as Holmes.

More than 200 people were summoned for the jury pool in an effort to seat an impartial panel.
Over the course of the next three months, the trial is expected to provide moments of high drama, featuring a cast of billionaire Theranos investors and influential figures that sat on the company’s board.
Investors who contributed much of the roughly $900 million that Theranos raised include media magnate Rupert Murdoch, Walmart’s Walton family, the family of former U.S. Education Secretary Becky DeVos and Mexican business mogul Carlos Slim. Theranos’ well=connected board included former U.S. Secretary of State Henry Kissinger, former U.S. Defense Secretary Gen. James Mattis, former U.S. Secretary of State and former U.S. Treasury Secretary George Shultz (now deceased) and former Wells Fargo Bank CEO Richard Kovacevich.

Holmes also may take the witness stand to defend herself, based on court documents filed leading up to the trial. If she does, her lawyers have indicated in recently unsealed filings that she will testify that some of her statements and actions while running Theranos were the result of “intimate partner abuse” inflicted by the company’s chief operating officer and her secret lover, Ramesh “Sunny” Balwani, who is facing multiple fraud charges in a separate trial.

Balwani’s attorney has denied Holmes’ allegations.
 
Just closed out the last of my stock ownership, 7 year investment yielding a tidy 1100% profit, figuring it was time now before the Capital Gains Tax gets jacked up or eliminated. Not a bad little gambit...
Smart! And many folks doing the same. Advice is to now pick those long term investments again, as we should see some sensible leadership along with more favorable tax treatment in the next 4-5 years. The more folks that can be educated, the less tax revenue which will make the upcoming tax debacle look like even more of a failure. 2021 would show a one year "pop" and hopefully revenue would go down significantly. Thanks for doing your part!! :)
 
📱 Fish Smarter with the NYAngler App!
Launch Now

Members online

Fishing Reports

Latest articles

Back
Top